Richard Vellacott

Chief Executive Officer, BiologIC Technologies

Richard is co-founder, CEO and Chair of BiologIC Technologies Limited. BiologIC’s integrated processing development platform enhances yields, process robustness and scalability of advanced biology products.  The platform, enabled by novel biocomputer technology, is a new category of machine built from fluidic processing chips designed like computer chips.  Our vision is to help customers engineer biology to solve enormous challenges faced by humanity (feeding 9.8 billion people by 2050, mitigating climate change and reducing the threat of diseases) in an environmentally sustainable, economically accessible way.

An authentic and passionate leader, Richard inspires transformational change through the alignment of purposeful vision, high performing talent and quality capital.  He creates significant value through executive leadership, vision and strategy, commercialisation of science, capital market expertise, cultural and organisational change and building operational scale.

In seven valuable years as interim CEO, deputy CEO, CFO, COO and Company Secretary, Richard was instrumental in growing Horizon Discovery Group plc from an emerging private company of £3m revenue in 2012 to a recognised global leader in gene editing delivering revenue of £60m at a valuation of £350m.  Richard delivered one of the most successful ever Life Science listings on AIM raising £68.6m in a heavily oversubscribed IPO at the top of its valuation range within 3 months, fundraisings in the UK and the US, four acquisitions and hostile bid defence.

Richard was previously Vice President, Finance at CSR plc, a dual listed FTSE 250 semiconductor company with $1bn of revenues, and a director in Deloitte’s life sciences practice.  Richard is a qualified chartered accountant with a first class degree in biological sciences from Durham University.

Leonardo Royal Hotel London Tower Bridge

16 May 2023